FEDERATED HERMES, INC. - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 85 filers reported holding UNITY BIOTECHNOLOGY INC in Q2 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2022$1,000
-50.0%
2,735
-24.8%
0.00%
Q2 2022$2,000
-50.0%
3,635
+4.4%
0.00%
Q1 2022$4,000
-73.3%
3,483
+107.8%
0.00%
Q2 2020$15,0001,6760.00%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q2 2020
NameSharesValueWeighting ↓
Mayo Clinic 1,571,981$7,294,0008.07%
Invus Financial Advisors, LLC 1,094,998$5,081,0001.01%
Founders Fund V Management, LLC 491,751$2,282,0000.78%
Tibra Equities Europe Ltd 80,700$374,0000.12%
GSA CAPITAL PARTNERS LLP 205,882$955,0000.11%
Hall Private Wealth Advisors 18,500$86,0000.06%
20/20 Capital Management, Inc. 42,840$199,0000.05%
OCCUDO QUANTITATIVE STRATEGIES LP 64,789$301,0000.05%
JACOBS LEVY EQUITY MANAGEMENT, INC 759,918$3,526,0000.02%
PDT Partners, LLC 74,178$344,0000.02%
View complete list of UNITY BIOTECHNOLOGY INC shareholders